Assessment of the Effectiveness of Menopur in Intrauterine Insemination

Completed

• Conditions: Infertility
• Interventions: Drug: hMG

• Registration Number: NCT01354834
• Lead Sponsor: Ferring Pharmaceuticals

Brief Summary

The purpose of this study is to assess the effectiveness of Menopur to achieve clinical pregnancy in females undergoing intrauterine insemination in clinical practice.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-03
• Primary Completion: 2005-12
• Study Completion: 2006-04
• Status Verified: 2011-05
• Study First Submitted: 2011-05-16
• Study First Submitted QC: 2011-05-16
• Last Update Submitted: 2011-05-16
• Study First Posted: 2011-05-17
• Last Update Posted: 2011-05-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 207

Inclusion Criteria

• Infertile couples for over one year (primary or secondary) or infertile women (or not) with indication of PAI or DAI
• Seminal sample suitable for artificial insemination treatment according to the criterion of each centre
• Patient prescribed therapy with Menopur in artificial insemination

Read More

Exclusion Criteria

• Contraindications to intrauterine insemination
• Contraindications to Menopur

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
hMG	hMG	-

Primary Outcome Measures

Name	Time	Method
Clinical pregnancy rate	30 days

Secondary Outcome Measures

Name	Time	Method
Live birth rate	40 weeks

Trial Locations

Locations (1)

Investigational site; 🇪🇸 Valladolid, Spain